Join Carsten Niemann, a leading hematological oncologist from Copenhagen University Hospital, as he delves into the transformative power of artificial intelligence in personalizing blood cancer care. Discover how AI enhances treatment for Chronic Lymphocytic Leukemia by predicting individual risks and improving decision-making. Niemann discusses a novel treatment infection model his team developed, while Gareth Morgan from NYU Langone highlights AI's role in classifying multiple myeloma patients and its potential to predict transplantation needs.